| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $332K | — | +226.6% |
| SG&A Expense | $397K | — | +48.4% |
| Operating Income | -$823K | — | -72.7% |
| Net Income | -$823K | +34.9% | -72.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $763K | -47.1% | -53.9% |
| Total Assets | $778K | -46.7% | -53.5% |
| Current Liabilities | $11K | +13.3% | -12.4% |
| Stockholders' Equity | -$2.7M | -33.5% | -52.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$723K | — | -46.6% |